Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Rheumatology (Oxford, England)|January 22, 2008
Prophylactic but not therapeutic activity of a monoclonal antibody that neutralizes the binding of VEGF-B to VEGFR-1 in a murine collagen-induced arthritis modelA W Mould, P Scotney, S A Greco, et al.Nature|December 12, 1991
A candidate spermatogenesis gene on the mouse Y chromosome is homologous to ubiquitin-activating enzyme E1G F Kay, A Ashworth, G D Penny, et al.The Journal of Experimental Medicine|July 7, 1998
Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cellsD R Fitzpatrick, K M Shirley, L E McDonald, et al.Cell|April 8, 1994
Evidence that random and imprinted Xist expression is controlled by preemptive methylationD P Norris, D Patel, G F Kay, et al.Oncogene|February 16, 1995
Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic miceR R Tönjes, J Löhler, J F O'Sullivan, et al.Cell|October 30, 1992
The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleusN Brockdorff, A Ashworth, G F Kay, et al.Nature|May 23, 1991
Conservation of position and exclusive expression of mouse Xist from the inactive X chromosomeN Brockdorff, A Ashworth, G F Kay, et al.Oncogene|February 14, 2017
Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activationI D Tonks, P Mukhopadhyay, W A Schroder, et al.Oncogene|December 19, 2006
Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout miceK A Loffler, C A Biondi, M G Gartside, et al.Circulation Research|February 10, 2000
Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemiaD Bellomo, J P Headrick, G U Silins, et al.Pageof 2